KYMR – kymera therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Kymera Therapeutics, Inc. (NASDAQ: KYMR) is now covered by analysts at BTIG Research. They set a "buy" rating and a $60.00 price target on the stock.
Kymera Therapeutics, Inc. (NASDAQ: KYMR) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $55.00 price target on the stock.
Kymera Therapeutics, Inc. (NASDAQ: KYMR) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $57.00 price target on the stock, up previously from $38.00.
Kymera Therapeutics to Participate in Upcoming December Investor Conferences [Yahoo! Finance]
Kymera Therapeutics to Participate in Upcoming December Investor Conferences
Form 4 Kymera Therapeutics, For: Dec 02 Filed by: Esposito Pamela
Form 144 Kymera Therapeutics, Filed by: Esposito Pamela
Form SC 13G/A Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Form SC 13G/A Kymera Therapeutics, Filed by: PRICE T ROWE ASSOCIATES INC /MD/
Form SC 13G/A Kymera Therapeutics, Filed by: Avoro Capital Advisors LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.